aTyr Pharma | LIFE - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Ardelyx USD 31.21M 36.79M 2026-03
aTyr Pharma USD 10.01M 735K 2026-03
Biogen USD 3.38B 374.2M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Curis USD 10.14M 10.14M 2025-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
United Therapeutics USD 1.28B 277.4M 2026-03
Xoma USD 143.9M 7.68M 2024-06